Ocular Pressure in Steroid-treated Dermatology Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-09-30

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ocular hypertension and glaucoma are eye conditions associated with abnormally high fluid pressure in the eye (called intraocular pressure or IOP). If left untreated, the elevated IOP may eventually cause damage to the nerve of the eye and potential impairment of vision.

The use of certain drugs has been identified as a risk factor for raised IOP, including various forms of administration of corticosteroids. Corticosteroids can also lead to cataract, which is clouding of the lens in the eye that can affect vision.

In this research study, we would like to find out whether the use of corticosteroids in our dermatology clinic leads to raised IOP, in order to identify patients at risk and to allow them to be more closely monitored than others. It is important to identify those patients who have a corticosteroid-induced pressure rise early enough to prevent them from permanent glaucomatous visual loss.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma

NCT02338362

Ocular Hypertension Glaucoma, Open-Angle

COMPLETED PHASE4

Effects of Topical Low Dose Preservative-free Hydrocortisone on Intraocular Pressure

NCT04536129

Ocular Surface Disease Glaucoma

COMPLETED NA

Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens

NCT00001161

Aniridia Eye Abnormality Ocular Hypertension +1 more

COMPLETED

IOP Elevation Study

NCT03400137

Intraocular Pressure

RECRUITING NA

Effects of a Single Osteopathic Manipulative Treatment (OMT) on Intraocular Pressure (IOP) Reduction

NCT03590249

Glaucoma

ENROLLING_BY_INVITATION NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Topical Corticosteroid-treated Dermatology Patients Intra-ocular Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Potent topical steroid-treated

Patients treated with potent topical steroids

Potent topical steroid

Intervention Type DRUG

Superpotent topical steroid-treated

Patients treated with superpotent topical steroids

Superpotent topical steroid

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Potent topical steroid

Intervention Type DRUG

Superpotent topical steroid

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients on whom corticosteroid treatment is being introduced for a duration of at least 12 weeks

Exclusion Criteria

* pregnant women
* patients already under glaucoma treatment
* patients unable to give informed written consent or those unable to cooperate fully with the assessments

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No